Loading...
Loading...
India's oxaliplatin imports from GERMANY total $217 across 2 shipments from 1 foreign suppliers. BASICS GMBH leads with $217 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SUN PHARMACEUTICAL INDUSTRIES LIMITED. This corridor reflects India's pharmaceutical import demand for oxaliplatin โ a concentrated sourcing relationship with select suppliers from GERMANY.

BASICS GMBH is the leading Oxaliplatin supplier from GERMANY to India, with import value of $217 across 2 shipments. The top 5 suppliers โ BASICS GMBH โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BASICS GMBH | $217 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $217 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Oxaliplatin suppliers from GERMANY to India include BASICS GMBH. The leading supplier is BASICS GMBH with import value of $217 USD across 2 shipments. India imported Oxaliplatin worth $217 USD from GERMANY in total across 2 shipments.
India imported Oxaliplatin worth $217 USD from GERMANY across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Oxaliplatin sourced from GERMANY include SUN PHARMACEUTICAL INDUSTRIES LIMITED. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES LIMITED with $217 in imports across 2 shipments.
The total value of Oxaliplatin imports from GERMANY to India is $217 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists